Popular on EntSun
- 'A Hot Set' Merges Various Digital News Departments
- Tobu Hotel Levant Tokyo's "Verdure" Restaurant Is Now Serving Fresh, Consistently High Quality, Vegetables Grown Inside the Restaurant Itself
- VSA Joins Prestigious Customer Care Association SOCAP
- Ready to plan a Wedding in Los Angeles in 3 Months? Part #3
- Ironton Continues Expansion with Launch of New Private Wireless Company, Keystone Metrofiber
- New Commemorative 0 Euro Banknote Celebrates Irish Free State's Centennial
- The Chemotherapy Foundation Honors Jersey Boys Tony® & Grammy Award® Winner Christian Hoff
- Tru by Hilton Expands to Illinois with Opening of Tru by Hilton Naperville Chicago, IL
- New "Black Friday Knife Deals" Article Out Now. One Is Free?
- Bizkitbnb Re-Launches the Casamigos Video Featuring Eric Bellinger in time for the Holiday Season
Similar on EntSun
- "Foodizz Academy Launches the First Learning Management System (LMS) Especially for Culinary Business"
- Cloudian Inc Licenses Cryptsoft KMIP SDK
- Businessman Ismail Sirdah Shares His Tips For Creating Quality Content For Social Media
- New consultancy launches to address poor communication within digital transformation projects
- National Minority Health Association Selected by Chan Zuckerberg Initiative for Grant
- Advantage Anywhere Launches a Joint Venture and Licensing Partner Program for the Senior Living Industry
- Sojazzie Home Girl of Delgado Realty & Real African Art Gallery's Home For The Holidays Give Back
- The Secret to Moving to London from the USA
- Get Doodle Videos - The Best Whiteboard Animation Software - For Only $49 This Black Friday & Cyber Week
- Bitcoin in Unique Leadership Position with Ethereum's Abandonment of Proof of Work*
Arcus Biosciences Announces New Employment Inducement Grants
EntSun News/10964990
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company's Board of Directors granted seven new employees options to purchase a total of 11,400 shares of the Company's common stock at an exercise price per share of $27.17, which was the closing price on November 23, 2022, and restricted stock units to acquire a total of 5,700 shares of the Company's common stock. The equity awards were granted pursuant to the Company's 2020 Inducement Plan, which was approved by the Company's Board of Directors in January 2020 pursuant to the "inducement exception" under NYSE Listed Company Manual Rule 303A.08.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well characterized biology and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of six investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and dual A2a/A2b) and most recently, HIF-2alfa. For more information about Arcus Biosciences' clinical and pre-clinical programs, please visit www.arcusbio.com or follow us on Twitter.
More on EntSun News
Inducement PR
Source: Arcus Biosciences
Contacts
Investor and Media Inquiries:
Holli Kolkey
VP of Corporate Communications
(650) 922-1269
hkolkey@arcusbio.com
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well characterized biology and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of six investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and dual A2a/A2b) and most recently, HIF-2alfa. For more information about Arcus Biosciences' clinical and pre-clinical programs, please visit www.arcusbio.com or follow us on Twitter.
More on EntSun News
- Panoramic Voices' Brings Joyful Music withs "FAs & LAs" and Central Texas Philharmonic
- 13th Annual Zed Fest Film Festival X-Mas Tales 2022 Film Winners Celebration Sun Dec 11,2022
- Meet & Greet Supermodel Beverly Johnson, Noire Women's Wellness Cover Model
- Books for Everyone: The Best Books of 2022 are Here!
- Cloudian Inc Licenses Cryptsoft KMIP SDK
Inducement PR
Source: Arcus Biosciences
Contacts
Investor and Media Inquiries:
Holli Kolkey
VP of Corporate Communications
(650) 922-1269
hkolkey@arcusbio.com
Filed Under: Business
0 Comments
Latest on EntSun News
- Stacy Rose stars in Apple TV+ series Season 2 "Little America"
- Businessman Ismail Sirdah Shares His Tips For Creating Quality Content For Social Media
- Florida Retirement Is Murder ~ Novel
- MESSIAH - Coming to Ontario California!
- D Love: A New Brand Setting The Standard For Luxury Fashion
- Promised Land. The trailer won a global award
- Award-Winning Artists Celebrate the Continued Success of Education Through Music-Los Angeles at their Gala on Nov 30th
- Twisted Sister Makeup Collection Launched by Rock and Roll Beauty
- First Friday Films ends 2022 with Carmen Milagro and J. D. Mata's "Spirit, Light & Love"
- Bethany Lord Joins Talent Concierge
- The East TOKYO Festival of Light launches in Tokyo, Presented by Tobu Railway Group
- Anthony Daniels, 'C-3PO' In 'Star Wars,' To Attend FAN EXPO Portland, February 17-19
- Yida Gao and Shima Capital Invest in Web3 Gaming Startup Midnight
- Max & Louie Productions Presents WHAT THE CONSTITUTION MEANS TO ME
- Teresa James Announces New Album, 'With A Little Help from Her Friends'
- Play time for edge computing is over—full scale deployments in 2023, predicts IOTech
- Kadrolsha Ona Carole Superhero
- New consultancy launches to address poor communication within digital transformation projects
- DJ Mark Battle Keeps Guests Groovin at Kahbran White & Niya Mohammed's Soulful Malibu Wedding
- ODK Media, Inc. Is Giving OnDemandKorea Its Biggest UI/UX Overhaul In 11 Years